SMALL CAP MOVERS: Futura’s erectile dysfunction breakthroughs fail to stir investors
It’s rare for a company to take a drug from the clinic to commercial success, but James Barder and his team at Futura Medical have done just that with their fast-acting erectile dysfunction (ED) gel, Eroxon.This week has been a pivotal…